iCAD Granted U.S. Patent on MRI Image Analysis Solutions (ICAD)

iCAD ICAD, an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces that the United States Patent and Trademark Office recently granted the company Patent Number 7,903,853. This patent covers iCAD's sophisticated magnetic resonance imaging (MRI) analysis products for breast and prostate cancer detection, and relates to the speed its image analysis solution pinpoints and marks areas that warrant closer inspection from a radiologist. iCAD's VividLook, SpectraLook and OmniLook utilize this technology to offer a comprehensive quantitative image analysis suite for cancer detection, localization, staging, treatment planning and serial monitoring.